Awiqli 2100 Unit (Insulin Icodec SOLUTION) 2100 UNIT

AWIQLI 2100 Unit Insulin Icodec is a subcutaneous solution designed for managing blood sugar levels in diabetes. This long-acting insulin offers a convenient once-weekly administration option.

Strength

2100 UNIT

Manufacturer / TM Owner

NOVO NORDISK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AWIQLI 2100 Unit Insulin Icodec is primarily used for the management of type 2 diabetes in adults. It helps control blood sugar levels, which is essential for preventing complications associated with diabetes. This medication is often prescribed for individuals who require long-acting insulin to maintain stable glucose levels throughout the week.

Side Effects

Common effects of AWIQLI 2100 Unit Insulin Icodec may include mild injection site reactions, such as redness or itching. Some users might experience hypoglycemia, characterized by symptoms like dizziness or sweating, if blood sugar levels drop too low. It's important to monitor blood sugar levels regularly while using this medication.

Precautions & Warnings

AWIQLI 2100 Unit Insulin Icodec should be stored properly to maintain its effectiveness. It is crucial to follow the storage instructions provided by the manufacturer. Always use a new needle for each injection to prevent contamination. Consult a healthcare provider before starting this medication, especially if you have a history of low blood sugar or other medical conditions.

Avoid Interactions

AWIQLI 2100 Unit Insulin Icodec may interact with other medications, including oral hypoglycemic agents and certain antihypertensive drugs. Alcohol consumption can also affect blood sugar levels and should be monitored carefully. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

AWIQLI 2100 Unit Insulin Icodec is used for managing blood sugar levels in adults with type 2 diabetes.

AWIQLI 2100 Unit Insulin Icodec is typically administered once weekly.

Common side effects may include injection site reactions and symptoms of hypoglycemia, such as dizziness or sweating.

AWIQLI 2100 Unit Insulin Icodec may interact with other diabetes medications, so it's important to consult a healthcare provider before combining treatments.

AWIQLI 2100 Unit Insulin Icodec should be stored according to the manufacturer's instructions to maintain its effectiveness.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.